» Articles » PMID: 28702218

Effects of a Parallel-arm Randomized Controlled Weight Loss Pilot Study on Biological and Psychosocial Parameters of Overweight and Obese Breast Cancer Survivors

Overview
Publisher Biomed Central
Date 2017 Jul 14
PMID 28702218
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Weight gain often occurs after breast cancer (BC) diagnosis and obesity along with sedentary behavior are associated with increased risk of BC recurrence and mortality. The primary objective of this study was to determine whether a significant weight loss, of approximately 10%, would lead to beneficial changes in biomarkers associated with cancer and/or cancer recurrence, and quality of life (QOL) in overweight and obese BC survivors.

Methods: This parallel-arm study took place in Minneapolis, Minnesota, from January 2009 until March 2010. Participants were overweight and obese postmenopausal BC survivors who had completed treatment at least 3 months prior to enrollment and who did not smoke. Twenty-one BC survivors were randomized, via a random number generator computer software, to a 1000-calorie deficit feeding and exercise intervention (CR) or a weight management counseling intervention (WM) for 12 weeks followed by a 6-week follow-up. Body weight, biomarkers, and QOL were measured at baseline, weeks 6, 12, and 18. Body composition and fitness level were measured at only two time points.

Results: Twenty-one women were enrolled into the study and 20 completed all time points. Weight loss occurred with both interventions. Body weight in CR changed from 85.5 (95% confidence interval (CI) 77, 94) kg to 76.7 (95% CI 68.1, 85.2) kg, whereas in WM it changed from 98.3 (95% CI 89.8, 106.8) kg to 93.2 (95% CI 84.6, 101.7) kg. Fitness in CR changed from 4.9 (95% CI 4, 5.8) to 6.3 (95% CI 5.4, 7.2). CR led to lower plasma levels of leptin, F2-isoprostanes, and CRP. Quality of life seemed to improve with both interventions, while sleep quality decreased only in CR.

Conclusions: Overweight and obese BC survivors were able to adhere to a strict diet and exercise program, which significantly decreased body weight, increased fitness level, and improved biomarkers and QOL. However, the strict dietary intervention in CR seemed to decrease participants' sleep quality and social relationships. Future larger randomized controlled trials should focus on behavioral modification and personalized nutrition counseling to help breast cancer survivors achieve a sustainable weight loss and fitness level.

Trial Registration: ClinicalTrials.gov identifier: NCT02940470.

Citing Articles

Narrative review of lifestyle interventions in breast cancer survivors: current evidence and future directions.

Gabel K, Chakos K, Oliveira M, Sanchez Perez J, Cares K, Lima N JNCI Cancer Spectr. 2024; 8(6.

PMID: 39447046 PMC: 11631304. DOI: 10.1093/jncics/pkae108.


Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review.

Buro A, Nguyen T, Abaskaron M, Haver M, Carson T Breast Cancer Res Treat. 2024; 206(1):1-18.

PMID: 38551752 DOI: 10.1007/s10549-024-07278-x.


WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Adiponectin and Leptin Levels in Breast Cancer Survivors with Overweight or Obesity.

Lin D, Sturgeon K, Gordon B, Brown J, Sears D, Sarwer D Nutrients. 2023; 15(15).

PMID: 37571390 PMC: 10421485. DOI: 10.3390/nu15153453.


Effects of Combined Interventions of Exercise and Diet or Exercise and Supplementation on Breast Cancer Patients: A Systematic Review.

Perez-Bilbao T, Alonso-Duenas M, Peinado A, San Juan A Nutrients. 2023; 15(4).

PMID: 36839371 PMC: 9964362. DOI: 10.3390/nu15041013.


Effect of Dietary-Based Lifestyle Modification Approaches on Anthropometric Indices and Dietary Intake Parameters in Women with Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Raji Lahiji M, Vafa S, de Souza R, Zarrati M, Sajadian A, Razmpoosh E Adv Nutr. 2022; 13(5):1974-1988.

PMID: 35641019 PMC: 9526840. DOI: 10.1093/advances/nmac062.


References
1.
Vrieling A, Seibold P, Johnson T, Heinz J, Obi N, Kaaks R . Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?. Int J Cancer. 2013; 134(12):2972-83. DOI: 10.1002/ijc.28628. View

2.
Murri A, Bartlett J, Canney P, Doughty J, Wilson C, McMillan D . Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer. 2006; 94(2):227-30. PMC: 2361117. DOI: 10.1038/sj.bjc.6602922. View

3.
Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T . Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis. 2012; 33(7):1319-26. DOI: 10.1093/carcin/bgs187. View

4.
Slattery M, Baumgartner K, Byers T, Guiliano A, Sweeney C, Herrick J . Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control. 2005; 16(10):1147-57. DOI: 10.1007/s10552-005-0318-2. View

5.
Milne G, Sanchez S, Musiek E, Morrow J . Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007; 2(1):221-6. DOI: 10.1038/nprot.2006.375. View